The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 16,538,504 | 90,821 | SH | SOLE | NONE | 90,821 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 2,049,943 | 51,714 | SH | SOLE | NONE | 51,714 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 1,057,467 | 147,485 | SH | SOLE | NONE | 147,485 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 4,092,656 | 61,590 | SH | SOLE | NONE | 61,590 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 13,480,185 | 34,238 | SH | SOLE | NONE | 34,238 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 1,651,200 | 40,000 | SH | SOLE | NONE | 40,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 2,402,696 | 15,894 | SH | SOLE | NONE | 15,894 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 12,923,448 | 190,752 | SH | SOLE | NONE | 190,752 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 7,010,270 | 87,848 | SH | SOLE | NONE | 87,848 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 530,007 | 35,452 | SH | SOLE | NONE | 35,452 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 1,870,910 | 6,905 | SH | SOLE | NONE | 6,905 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,014,660 | 85,765 | SH | SOLE | NONE | 85,765 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 6,276,598 | 89,525 | SH | SOLE | NONE | 89,525 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 5,419,110 | 87,040 | SH | SOLE | NONE | 87,040 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 3,392,264 | 119,488 | SH | SOLE | NONE | 119,488 | 0 | 0 | ||
EFFECTOR THERAPEUTICS INC | CALL | 28202V907 | 359,750 | 25,000 | SH | Call | SOLE | NONE | 25,000 | 0 | 0 | |
ELI LILLY & CO | COM | 532457108 | 72,033,650 | 92,593 | SH | SOLE | NONE | 92,593 | 0 | 0 | ||
ELI LILLY & CO | PUT | 532457958 | 89,465,400 | 115,000 | SH | Put | SOLE | NONE | 115,000 | 0 | 0 | |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,064,505 | 51,500 | SH | SOLE | NONE | 51,500 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 244,587 | 95,170 | SH | SOLE | NONE | 95,170 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 2,303,349 | 52,492 | SH | SOLE | NONE | 52,492 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 691,337 | 21,397 | SH | SOLE | NONE | 21,397 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 3,207,743 | 118,236 | SH | SOLE | NONE | 118,236 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 14,538,643 | 210,096 | SH | SOLE | NONE | 210,096 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 1,805,280 | 47,949 | SH | SOLE | NONE | 47,949 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 842,066 | 39,478 | SH | SOLE | NONE | 39,478 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 441,662 | 58,190 | SH | SOLE | NONE | 58,190 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 942,183 | 64,007 | SH | SOLE | NONE | 64,007 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 415,781 | 1,557 | SH | SOLE | NONE | 1,557 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 50,035,440 | 379,200 | SH | SOLE | NONE | 379,200 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 1,390,485 | 421,359 | SH | SOLE | NONE | 421,359 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 2,259,200 | 50,171 | SH | SOLE | NONE | 50,171 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 6,206,400 | 45,000 | SH | SOLE | NONE | 45,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 1,283,840 | 54,285 | SH | SOLE | NONE | 54,285 | 0 | 0 | ||
NOVO-NORDISK A S | ADR | 670100205 | 88,819,801 | 691,743 | SH | SOLE | NONE | 691,743 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 6,594,634 | 724,685 | SH | SOLE | NONE | 724,685 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,490,000 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 274,346 | 86,002 | SH | SOLE | NONE | 86,002 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,600,049 | 124,440 | SH | SOLE | NONE | 124,440 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 1,233,026 | 137,308 | SH | SOLE | NONE | 137,308 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 1,133,482 | 52,476 | SH | SOLE | NONE | 52,476 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 1,751,547 | 40,924 | SH | SOLE | NONE | 40,924 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 2,654,435 | 53,930 | SH | SOLE | NONE | 53,930 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 5,208,979 | 76,255 | SH | SOLE | NONE | 76,255 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 1,047,730 | 24,298 | SH | SOLE | NONE | 24,298 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 2,104,411 | 130,790 | SH | SOLE | NONE | 130,790 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 12,080,489 | 28,900 | SH | SOLE | NONE | 28,900 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 35,553,560 | 433,580 | SH | SOLE | NONE | 433,580 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,722,000 | 40,000 | SH | SOLE | NONE | 40,000 | 0 | 0 |